Cancer

Guo Guangchang’s Letter to Shareholders: Fosun International Pursues Progress through “Strategic Advancements and Exits”

HONG KONG, March 31, 2025 /PRNewswire/ -- Guo Guangchang, Chairman of Fosun International Limited (HKEX: 0656), issued a letter to…

9 months ago

Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Risk

--Data presented at the American College of Cardiology Annual Scientific Session show that the reduction of bleeding with abelacimab compared…

9 months ago

Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates

SHANGHAI, March 28, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading…

9 months ago

Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results

SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a biotechnology company…

9 months ago

Castle Biosciences’ DecisionDx®-SCC Data Earns Top Five Abstract at NCCN 2025, Shows Significantly Enhanced Risk Stratification Beyond Current Staging Within NCCN Risk Groups

New, combined validation cohort of 1,412 patients with high-risk squamous cell carcinoma (SCC) demonstrates that the addition of DecisionDx-SCC to…

9 months ago

Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

– Alignment reached with U.S. Food and Drug Administration on key elements of the approval pathway for Olvi-Vec in Platinum Resistant/Refractory…

9 months ago

Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates

JERUSALEM, March 28, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides…

9 months ago

Antithrombin Blood Test from Siemens Healthineers Now FDA Cleared as a Companion Diagnostic for Qfitlia, a Sanofi Hemophilia Therapy

The assay now can measure antithrombin (AT) activity levels for people treated with Qfitlia Measuring AT activity levels helps people…

9 months ago

Studying Cardiac Cells in Space to Repair Heart Damage on Earth

ISS National Lab-sponsored research is accelerating the development of regenerative therapies that could one day reverse heart damage—learn more in…

9 months ago

Growth Executive, Andrew Candreva, Joins Tantus Tech as Director of Strategy

ARLINGTON, Va., March 28, 2025 /PRNewswire/ -- Tantus Technologies, Inc. (Tantus), a leader in the federal IT consulting, is excited to…

9 months ago